Eileen Brantley

537 total citations
20 papers, 459 citations indexed

About

Eileen Brantley is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Eileen Brantley has authored 20 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Eileen Brantley's work include Bioactive Compounds and Antitumor Agents (5 papers), Estrogen and related hormone effects (5 papers) and Synthesis and biological activity (4 papers). Eileen Brantley is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Estrogen and related hormone effects (5 papers) and Synthesis and biological activity (4 papers). Eileen Brantley collaborates with scholars based in United States, Argentina and Jamaica. Eileen Brantley's co-authors include Edward A. Sausville, Sherman F. Stinson, Tracey D. Bradshaw, Malcolm F. G. Stevens, Keli Agama, Yves Pommier, Ubaldo Soto, Mei‐Sze Chua, Eiji Kashiyama and Lawrence C. Sowers and has published in prestigious journals such as Cancer Research, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eileen Brantley

20 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eileen Brantley United States	10	199	153	89	69	62	20	459
André Stander South Africa	15	292 1.5×	114 0.7×	70 0.8×	57 0.8×	12 0.2×	34	506
Guiqing Liang United States	11	171 0.9×	104 0.7×	55 0.6×	15 0.2×	58 0.9×	21	484
Stephanie L. Coffing United States	14	309 1.6×	73 0.5×	140 1.6×	293 4.2×	99 1.6×	26	649
Matic Pavlin Italy	12	134 0.7×	99 0.6×	78 0.9×	12 0.2×	20 0.3×	22	377
Franco Buzzetti Italy	13	302 1.5×	65 0.4×	113 1.3×	86 1.2×	112 1.8×	21	586
Telih Boyiri United States	12	182 0.9×	24 0.2×	69 0.8×	74 1.1×	71 1.1×	19	500
Vinay R. Sonawane India	12	215 1.1×	116 0.8×	80 0.9×	36 0.5×	105 1.7×	21	376
Claire Colas United States	18	484 2.4×	56 0.4×	264 3.0×	69 1.0×	25 0.4×	29	801
Solveigh C. Koeberle Germany	10	288 1.4×	81 0.5×	41 0.5×	79 1.1×	11 0.2×	15	484
Rakesh Sathish Nair United States	15	249 1.3×	50 0.3×	139 1.6×	62 0.9×	22 0.4×	28	485

Countries citing papers authored by Eileen Brantley

Since Specialization

Citations

This map shows the geographic impact of Eileen Brantley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Brantley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Brantley more than expected).

Fields of papers citing papers by Eileen Brantley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Brantley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Brantley. The network helps show where Eileen Brantley may publish in the future.

Co-authorship network of co-authors of Eileen Brantley

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Brantley. A scholar is included among the top collaborators of Eileen Brantley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Brantley. Eileen Brantley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loaiza‐Perez, Andrea, et al.. (2023). Triumphs and challenges in exploiting poly(ADP‐ribose) polymerase inhibition to combat triple‐negative breast cancer. Journal of Cellular Physiology. 238(8). 1625–1640. 2 indexed citations

Delgoda, Rupika, et al.. (2022). Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells. Fitoterapia. 160. 105203–105203. 3 indexed citations

Liu, Tiantian, Salma Khan, Xin Chen, et al.. (2022). Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties. Precision Clinical Medicine. 5(2). pbac008–pbac008. 3 indexed citations

Roy, Monika A., et al.. (2021). Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of the aryl hydrocarbon receptor. Toxicology and Applied Pharmacology. 419. 115502–115502. 9 indexed citations

Davis, Melissa B., et al.. (2020). Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes. Cancer Letters. 500. 64–74. 9 indexed citations

Unternaehrer, Juli, et al.. (2018). Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand–mediated triple negative breast cancer cell death. Journal of Cellular Biochemistry. 120(4). 6004–6014. 14 indexed citations

Khan, Salma, Ubaldo Soto, Andrea Loaiza‐Perez, et al.. (2018). AhR ligand aminoflavone suppresses α6‐integrin–Src–Akt signaling to attenuate tamoxifen resistance in breast cancer cells. Journal of Cellular Physiology. 234(1). 108–121. 35 indexed citations

Badal, Simone, Malyn May Asuncion Valenzuela, George Q. Huang, et al.. (2017). Glaucarubulone glucoside from Castela macrophylla suppresses MCF‐7 breast cancer cell growth and attenuates benzo[a]pyrene‐mediated CYP1A gene induction. Journal of Applied Toxicology. 37(7). 873–883. 5 indexed citations

Brantley, Eileen, Damián E. Berardi, Marina Simian, et al.. (2016). AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity. Cancer Letters. 376(1). 53–61. 34 indexed citations

10.

Scott, Lia C., et al.. (2015). Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells. Chemical Research in Toxicology. 28(5). 855–871. 26 indexed citations

11.

Saulsbury, Marilyn D., et al.. (2014). One-pot synthesis of cinnamylideneacetophenones and their in vitro cytotoxicity in breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 24(15). 3381–3384. 24 indexed citations

12.

Brantley, Eileen, et al.. (2013). Apoptotic mechanism of novel anticancer agents is mediated by MAPKs in breast cancer cells. The FASEB Journal. 27(S1). 1 indexed citations

13.

Xu, Dan, et al.. (2011). Effects of l-DOPA on Nigral Dopamine Neurons and Local Field Potential: Comparison with Apomorphine and Muscimol. Journal of Pharmacology and Experimental Therapeutics. 337(2). 533–539. 5 indexed citations

14.

Sowers, Lawrence C., et al.. (2008). 5F 203-induced apoptosis involves oxidative stress and caspase activation in sensitive breast cancer cells. Cancer Research. 68. 1448–1448. 1 indexed citations

15.

Brantley, Eileen, et al.. (2007). Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients. Cancer Epidemiology and Prevention Biomarkers. 16. 1 indexed citations

16.

Soto, Ubaldo, Keli Agama, Randi M. Jimenez, et al.. (2007). Aminoflavone induces oxidative DNA damage and reactive oxidative species‐mediated apoptosis in breast cancer cells. International Journal of Cancer. 122(7). 1665–1674. 80 indexed citations

17.

Brantley, Eileen, Vyomesh Patel, Sherman F. Stinson, et al.. (2005). The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-??B activity in drug-sensitive MCF-7 cells. Anti-Cancer Drugs. 16(2). 137–143. 30 indexed citations

18.

Brantley, Eileen, Smitha Antony, Glenda Kohlhagen, et al.. (2005). Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Cancer Chemotherapy and Pharmacology. 58(1). 62–72. 38 indexed citations

19.

Brantley, Eileen, Valentina Trapani, Michael C. Alley, et al.. (2004). FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS. Drug Metabolism and Disposition. 32(12). 1392–1401. 47 indexed citations

20.

Chua, Mei‐Sze, Eiji Kashiyama, Tracey D. Bradshaw, et al.. (2000). Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.. PubMed. 60(18). 5196–203. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact